Analyst Ratings for Sienna Biopharmaceuticals (SNNA)

SNNA Rating Summary

  |   Expand Research on SNNA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/13/2019 JPMorgan Christopher Schott Downgrade Neutral
(Overweight)		 N/A
(N/A)		 1.63
(0.14)		 -91.41% Details
12/6/2017 Guggenheim N/A New Coverage Neutral
(N/A)		 21.00
(N/A)		 20.85
(0.14)		 -99.33% Details